Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins

View resource
HDx

The Efficacy of Post-Dilution Online Hemodiafiltration and Medium Cut-Off Dialyser on the Removal of Protein-Bound Uremic Toxins

View resource
HDx

A Randomized, Open-Label, Crossover Clinical Study to Compare the Effect of Hemodialysis Performed With a Medium Cut-Off Membrane vs. That With a High-Flux Membrane on Endothelial Function

View resource
HDx

Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic T

View resource
HDx

Evaluation of VIE-X Filter Performances vs. Medium Cut-Off Dialyzer and High-Flux Dialyzers on Protein Loss and Inflammatory Status of Chronic Hemodialysis Patients

View resource
HDx

Expanded Dialysis With Theranova Compared to Conventional High-Flux Hemodialysis: A Randomized Prospective 12-Month Study

View resource
HDx

Improved Removal of Free Light Chains by Hemodialysis With Medium Cut-Off Dialyzer

View resource
HDx

Improved Serum Phosphorous and Small Molecule Removal With Expanded Hemodialysis and Hemodiafiltration vs. Conventional Hemodialysis: A Cross-Over Randomized Clinical Trial

View resource
HDx

On the Removal of Middle Molecules and Albumin Loss: An Ex Vivo Evaluation of Commercial Dialyzers

View resource
HDx

Comparative Effectiveness between Expanded Hemodialysis (Hemodialysis Using a Medium Cut-Off Dialyzer) and Mixed-Dilution Online Hemodiafiltration Using a High-Flux Dialyzer in Removing Middle-Molecule Uremic Toxins

View resource
HDx

Fluctuations in Interleukin-6 Levels during Hemodialysis Sessions with Medium Cutoff Membranes: An Analysis on COVID-19 Case Series

View resource
HDx

Use of regional citrate anticoagulation with medium cut-off membrane: pilot report

View resource